Skip to main content
DEN Open logoLink to DEN Open
. 2021 Sep 5;2(1):e54. doi: 10.1002/deo2.54

Endoscopic resection of superficial non‐ampullary duodenal epithelial tumor

Motohiko Kato 1,2,, Takanori Kanai 1, Naohisa Yahagi 2
PMCID: PMC8828234  PMID: 35310765

Abstract

Although superficial non‐ampullary duodenal epithelial tumor (SNADET) was previously considered a rare disease, in recent years, the opportunities to detect and treat SNADET are increasing. Considering the high morbidity of pancreatoduodenectomy, endoscopic resection can be a treatment option that preserves the organs and contributes maintain patients’ quality of life. Endoscopic mucosal resection (EMR) is a standard treatment for relatively small lesions in gastrointestinal tracts, however, it is difficult because submucosal fibrosis frequently occurs due to the previous biopsy. Recently, some modified EMR techniques including underwater EMR (UEMR) and cold polypectomy (CP) have been proposed. In UEMR, the duodenal lumen is filled with water or saline and resected the targe lesion with a snare without injection into the submucosa. It would be a treatment option that could reduce candidates for ESD especially SNADET less than 20 mm. CP was reported as a safe and convenient means for SNADET. It would also be one of the standard treatments for diminutive lesions, though there remain some concerns on its resectability. ESD for SNADET is technically challenging, especially with an extremely high risk of adverse event (AE) with a reported bleeding rate of more than 20% and perforation rate up to about 40%. However, modified treatment techniques including the water pressure method and pocket creation method have been reported to potentially contribute to improving outcomes of ESD. Moreover, accumulated evidence shows closing the mucosal defect significantly reduces delayed adverse events after duodenal endoscopic treatments. Further studies are warranted to elucidate curative criteria, long‐term outcomes, and appropriate surveillance strategy.

Keywords: duodenum, endoscopic resection, outcomes

INTRODUCTION

A superficial non‐ampullary duodenal epithelial tumor (SNADET) was previously considered a rare disease. 1 , 2 , 3 , 4 Autopsy series have reported its estimated prevalence of 0.02%–0.5%. 5 , 6 , 7 However, in recent years, advances in endoscopic techniques and increased awareness of this disease by endoscopists have led to increased opportunities to detect SNADET. 8 , 9

Pancreaticoduodenectomy (Whipple's procedure) is the standard treatment for duodenal cancer. However, the substantial morbidity and mortality rates of Wipple's procedure are 30%–40% and 1%–4%, respectively, 10 , 11 , 12 , 13 and it is considered too invasive for SNADET. 14 Endoscopic resection (ER) is an alternative treatment for SNADET, which can preserve the organ and thus maintain the patient's postoperative quality of life. There are two main methods for ER of the duodenum: endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). Moreover, recently, some modified EMR techniques including underwater EMR (UEMR) and cold polypectomy (CP) have been proposed. In this review, we focus on the current status and recent advances in duodenal ER.

UNDERLYING ISSUES ON ER FOR SNADET

Since the duodenum is surrounded by various organs such as the pancreas and bile ducts, surgical resections including Wipple's procedure are highly invasive with the substantial morbidity and mortality of pancreaticoduodenectomy (PD) ranges 30%–40% and 1%–4%, respectively. 10 , 11 , 12 , 13 ER can preserve the organs and contributes maintain patients’ quality of life. On the other hand, ER of the duodenum is technically more difficult and the risk of delayed AE is higher than that of other organs due to various anatomical features as described below. First, the distance of the duodenum from the mouth and the flexure of the lumen (for example, superior and inferior duodenal angles) make it difficult to maneuver the endoscope and sometimes difficult to even approach the lesion. Second, the duodenal wall is extremely thin and can be easily perforated. In addition, a preoperative biopsy may reveal severe fibrosis, making endoscopic resection of even small lesions difficult and sometimes impossible. 15 Furthermore, due to exposure to bile and pancreatic juice from the duodenal papillae, the risk of delayed AE such as bleeding or perforation is much higher than in other organs, even if the treatment is completed safely. 16 In fact, previous reports on endoscopic treatment of SNADET have shown that the perforation rate is 13%–50% and the posterior bleeding rate is about 20%, 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 indicating a high risk of accidental injury. In the case of delayed perforation, surgical intervention may require highly invasive surgery such as pancreaticoduodenectomy or prolonged hospitalization even if conservative treatment is possible.

CONVENTIONAL EMR

EMR is a standard treatment for relatively small lesions in gastrointestinal tracts which consists of mainly 3 steps: local injection into the submucosal layer, strangulation of the target lesion with snare forceps, and resection using electrical current. Even in duodenal EMR, intraoperative perforation is relatively rare, with a reported incidence of around 1%. 22 , 25 On the other hand, there was a difference in the incidence of postoperative bleeding, 12% (14 out of 121 cases reported by Nonaka et al. 22 ) and 1.4% (2 out of 146 cases reported by Yahagi et al. 25 ). Although the detailed reason for the difference in results between these two reports is unclear, one possible factor may be the different lesion sizes. The former study included piecemeal resection of large lesions and the maximum diameter of the included lesions was 50 mm. 22 Larger mucosal defects after resection may be related to an increased risk of delayed bleeding.

In general, colorectal tumors can be resected en bloc by EMR as far as the lesion size is limited to less than 20 mm in diameter, and ESD is not necessary for these lesions. On the other hand, Yahagi et al. reported that ESD was performed for more than 20% of duodenal lesions less than 20 mm. 25 One of the reasons why EMR is difficult in relatively small lesions is the fibrosis of the submucosa induced by prior biopsy. In the duodenum, where the mucosa and submucosa are thin, only a tiny biopsy can lead to quite severe submucosal fibrosis, which often results in non‐lifting signs, making snaring impossible even in the small lesion. 15

UNDERWATER EMR

UEMR is a new endoscopic procedure in which the duodenal lumen is filled with water or saline and resected the targe lesion with a snare without injection into the submucosa, which was reported by Binmoeller et al. 26 in 2013 (Figure 1). There is a concern that the risk of perforation might be increased in UEMR by not performing local injection into the submucosa. However, in fact, intraoperative perforation of UEMR is reported to be very rare 26 , 27 , 28 , 29 , 30 , 31 , 32 (Table 1). This may be because, unlike the semilunar folds of the colon, the duodenal Kerckring folds consist of only mucosa and submucosa and do not contain the muscularis propria. Therefore, the flattened muscularis propria by filling the lumen with fluid, and the difference in specific gravity between the mucosa/submucosa and the muscularis propria reduce the risk of entrapment of the muscularis propria by the snare.

FIGURE 1.

FIGURE 1

Underwater endoscopic mucosal resection (EMR) for a superficial non‐ampullary duodenal epithelial tumor (SNADET). (a) A 15 mm‐flat elevated lesion is located on descending part of the duodenum. (b, c) The lesion was captured by a snare after filling the lumen with normal saline. (d) The lesion was resected in a single piece without any adverse events. (e) The mucosal defect was completely closed using endoclips. (f) Resected specimen. Pathological findings revealed low‐grade adenoma with free horizontal and vertical margins

TABLE 1.

Outcomes of duodenal underwater endoscopic mucosal resection (EMR)

Author Year Design Number of cases Bleeding Perforation En bloc resection R0 resection
Binmoeller 2013 Prospective 12 25% 0% 0% 0%
Yamasaki 2018 Prospective 31 0% 0% 87% 61%
Shibukawa 2018 Retrospective 16 0% 0% 88% NA
Kiguchi 2019 Retrospective 104 2% 0% 87% 67%
Iwagami 2020 Retrospective 162 0.6% 0% 68% NA
Hirasawa 2021 Retrospective 67 4.5% 0% 93% 76%
Furukawa 2021 Retrospective 28 0% 0% 96% 71%

NA: not applicable

Omitting local injection into the submucosa provides several advantages. First, the ability to obtain a good local injection that facilitates snaring is influenced by the location of the lesion and the skill of the endoscopist, whereas UEMR is not affected by these factors. Second, there are rich blood vessels in the submucosa of the duodenum, and injury by injection needle may cause massive bleeding or hematoma formation in the submucosa. UEMR would avoid this unnecessary adverse event. Third, in the duodenum, the Kerckring fold only consists of mucosa and submucosa and it doesn't contain muscularis propria. Therefore, submucosal injection results in stretching the mucosa and making it difficult to capture the target lesion. Furthermore, one of the most important advantages of this technique is that UEMR reduces the influence of fibrosis in the submucosa by omitting injection. In the duodenum, even a small mucosal biopsy prior to treatment can cause severe submucosal fibrosis. 15 In fact, Kiguchi et al. reported that 30% of duodenal tumors of 20 mm or less that had been planned to be treated with conventional EMR were actually converted to ESD due to technical difficulty, whereas the conversion to ESD was limited in only 15% in UEMR. 29 There was also a case of local residual recurrence after duodenal EMR was successfully treated by UEMR. 33 Moreover, recently a multi‐center prospective study revealed a 97% of the non‐recurrence rate of UEMR. 34 Based on these findings, UEMR has been regarded as one of the standard therapeutic options for SNADET less than 20 mm.

On the other hand, one of the issues of UEMR is that the omission of injection may increase the risk of positive lateral margins. Visibility of the anal margin of the lesion during snaring often is impaired due to the duodenal flexure and Kerckring folds and results in residual lesions in that area. Actually, there is a report describing that the proportion of R0 resection is slightly lower than that of conventional EMR, especially for large lesions. 29 To overcome this, a modified UEMR technique with only partial submucosal injection has been reported 35 , 36 , 37 (Figure 2). The detailed outcomes of this modified technique are still unknown and further studies are warranted.

FIGURE 2.

FIGURE 2

Underwater endoscopic mucosal resection (EMR) with partial submucosal injection for a superficial non‐ampullary duodenal epithelial tumor (SNADET). (a, b) A 15 mm‐flat elevated lesion is located on descending part of the duodenum. (c) Hyaluronic acid was injected only distal edge of the lesion after filling the lumen with normal saline. (d, e, f) The lesion was resected in a single piece without any adverse events. (g) Resected specimen. Pathological findings revealed low‐grade adenoma with free horizontal and vertical margins

COLD POLYPECTOMY

Cold polypectomy (CP) is a recently reported new endoscopic treatment for the gastrointestinal tract which is getting popular along with UEMR. There are two kinds of CP: Cold snare polypectomy (CSP), in which the lesion is physically resected without electric current after strangulation with a snare, and Cold forceps polypectomy, in which the lesion is removed like endoscopic biopsy with jumbo biopsy forceps. It has been suggested that the omission of using electric current in CP may reduce the risk of a late postoperative adverse event, and in fact, it was reported that CSP significantly reduced posterior bleeding compared with conventional EMR with an electric current in patients with colorectal polyps taking anticoagulant medication 38 and CP has become popular as a safe and convenient treatment method for colorectal adenomas.

There are also some reports about CP for SNADET. Maruoka et al. prospectively performed CP for 39 lesions in 30 patients and reported there were no AE, 39 and Hamada et al. performed CSP for 10 patients with familial adenomatous polyposis coli and resected dozens of lesions at once, but reported no serious AE 40 (Figure 3). Even though these reports are relatively small, and the safety and effectiveness of CP for SNADET should be confirmed further study, it is expected as a promising treatment option, especially for small lesions in the duodenum, where ER is at higher risk of AE than other organs.

FIGURE 3.

FIGURE 3

Cold snare polypectomy for multiple adenomatous lesions in patients of familial adenomatous polyposis syndrome. (a) Multiple adenomatous lesions were found in descending duodenum. (b) Lesions were resected by cold snare polypectomy. (c) Post resection mucosal defects. The patient was discharged a day after the procedure without any adverse event

On the other hand, there are also some concerns of CP that should be noted. One is an AE unique to the duodenum such as acute pancreatitis. Akimoto et al. reported a case of severe acute pancreatitis that occurred immediately after resection of a small lesion by cold forceps polypectomy locating the oral side of the papilla of Vater. In this case, acute pancreatitis was caused by edema of the minor papilla in a case of pancreatic divisum. 41 We should pay attention to this rare but serious AE as a precondition for widespread use of CP. The other concern is that CP may be inferior to other kinds of ER in resectability. It has been reported that only the muscularis mucosae and very shallow submucosa are resected in the CSP of the colon. 42 In fact, there are reports of cases in which local recurrence after CP was found as advanced cancer in the rectum. 43 Endoscopic diagnosis is less established in the duodenum than in the colon and biological malignancy of SNADET has not been clarified, thus it is still controversial whether to perform CP for all small SNADET uniformly.

ENDOSCOPIC SUBMUCOSAL DISSECTION

ESD is generally known to provide a secure local cure for early malignancies of the gastrointestinal tract 44 , 45 , 46 , 47 (Table 2). Similarly, in the duodenum, ESD has been reported to achieve a high en bloc resection rate, regardless of the size of the lesion. 17 , 19 , 22 , 23 , 24 , 25 , 31 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 Secure local resectability is one of the greatest advantages of ESD for reducing local residual recurrence. In fact, it has been reported that local recurrence occurs up to 30% of large lesions in the duodenum when the resection results in piecemeal resection 22 , 24 , 58 , 59 , 60 , 61 , 62 (Table 3). Another advantage of en bloc resection is the ability to make an accurate pathological diagnosis, and the high quality of the specimens obtained by ESD makes it possible to pick up subtle findings including slight submucosal invasion or lymphovascular involvement that is difficult to predict by endoscopic observation.

TABLE 2.

Short‐term outcomes of duodenal endoscopic submucosal dissection (ESD)

Author Year Design Number of cases Bleeding Perforation En bloc resection R0 resection
Draganov 2021 Prospective 11 9% 0% 91% 73%
Hirasawa 2021 Retrospective 64 5% 22% 98% 95%
Esaki 2020 Retrospective 55 0 14% 82% 71%
Kuroki 2020 Retrospective 7 14% 14% 86% 71%
Yahagi 2018 Retrospective 174 3% 9% 97% 83%
Tashima 2018 Prospective 50 8% 10% 100% 88%
Matsuda 2017 Retrospective 23 5% 26% NA NA
Hoteya 2017 Retrospective 74 15% 28% 99% 88%
Miura 2017 Retrospective 45 9% 16% 98% 82%
Ishii 2015 Retrospective 16 0% 6% 94% 81%
Nonaka 2015 Retrospective 8 0% 25% 75% 50%
Matsumoto 2014 Retrospective 15 20% 20% 87% 87%
Yamamoto 2014 Retrospective 30 0% 9% 100% 90%
Kakushima 2014 Retrospective 13 0% 31% 100% 92%
Jung 2013 Retrospective 14 7% 36% 86% 79%
Endo 2010 Retrospective 5 0% 20% 100% 100%
Honda 2009 Retrospective 9 22% 22% 100% NA

NA: not applicable

TABLE 3.

Local recurrence rate of duodenal endoscopic resection (ER)

Author Year Design Number of cases Treatment Piecemeal resection rate Observation period Recurrence rate
Hoteya 2017 Retrospective 129 EMR/ESD 10.1% 60.2 months 1.6%
Hara 2019 Retrospective 131 EMR/ESD 10.2% 43 months 3.1%
Nonaka 2015 Retrospective 113 Polypectomy/EMR/ESD 36.0% 51 months 0%
Valli PV 2017 Retrospective 78 EMR 64.1% 33 months 0%
Tomizawa 2018 Retrospective 142 EMR 47.0% 18.8 months 22.5%
Valerii 2018 Retrospective 68 EMR 44.0% 59 months 27.3%
Klein 2017 Retrospective 102 EPMR 100.0% 27 months 17.7%

Abbreviations: EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

On the other hand, it has been reported that ESD for SNADET is technically challenging, especially with an extremely high risk of AE with a reported bleeding rate of more than 20% and perforation rate up to about 40% 17 , 19 , 22 , 23 , 24 , 25 , 31 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 (Table 2). Factors that make duodenal ESD technically difficult include the following: maneuverability of the endoscope is limited in the duodenum, which is far from the mouth and fixed to the retroperitoneum. The wall is very thin and the space in the submucosa is narrow due to the rich Brunner's gland. The blood vessels are rich in submucosa, and even a small blood vessel can easily cause major bleeding. Therefore, duodenal procedures should be performed only by highly experienced endoscopists in high‐volume centers. Moreover, factors affecting technical difficulties, such as intraoperative perforation and long time required, have been analyzed, and the presence of lesions at bends such as the superior or inferior duodenal angle (odds ratio, 2.6), lesion diameter exceeding 40 mm (odds ratio, 5.3), and circumference occupied by the tumor exceeding half the circumference (odds ratio, 5.8) were reported as predictors for difficult ESD. 63

Although duodenal ESD is technically challenging as described above, several improved treatment techniques and newly developed devices have been reported. Yahagi et al. invented a water pressure method in which duodenal lumen is filled with normal saline and an active water stream is utilized to visualize submucosa 64 (Figure 4). The water pressure method improves the visibility of the submucosa especially in the early stage of submucosal dissection, when it is difficult to directly visualize submucosa, and in the dissection of the lateral edge of the target lesion. The water pressure method was reported to reduce intraoperative perforation and shorten treatment time. 65 In addition, Miura et al. reported the usefulness of the pocket creation method in duodenal ESD, which utilizing a small tip hood to dissect the submucosa making a pocket without making a full circumferential incision. The pocket creation method is thought to contribute to safety by stabilizing the endoscope and improve the visibility of submucosa. 53 Dohi et al. also reported the usefulness of the scissors‐type knife for duodenal ESD. 66 Furthermore, there is also a small case series reporting the usefulness of the traction device. 67

FIGURE 4.

FIGURE 4

Endoscopic submucosal dissection (ESD) using the water pressure method. (a) A 40 mm‐flat elevated lesion was found in descending duodenum. (b, c) Mucosal incision. (d, e) Hitting the water to submucosa contributed to improved visibility of dissecting area. (f) The lesion was resected without any adverse event

Although the outcomes of duodenal ESD have improved in recent years due to the above‐mentioned improvement of endoscopic technique and instruments, intraoperative perforation is still considered to be a hazardous AE, sometimes requiring highly invasive intervention including Whipple's procedure. Fukuhara et al. analyzed the clinical course of 32 patients with intraprocedural perforation during duodenal ESD and they found that if the whole mucosal defect including perforation, not only the perforation site, was closed completely, the clinical course was significantly better than those with incomplete closure and was equivalent to those without perforation. 68

MANAGEMENT AND PREVENTION OF DELAYED AE

As mentioned above, duodenal ER is at high risk of delayed AE including perforation or bleeding, due to exposure of bile, pancreatic juice, or intestinal juice to the post‐ER ulcer bed. 16 , 19 , 22 , 25 Various methods have been reported to prevent accidental injury during endoscopic treatment, including simple closure by clips, string clip suturing method (Figure 5), endloop/clips technique, Over‐The‐Scope Clips, or covering with polyglycolic acid sheets. 24 , 51 , 69 , 70 , 71 , 72 Kato et al. reported the proportion of delayed AE was only 1.7% in cases complete closure of the mucosal defect after duodenal ESD was achieved, whereas those in cases with incomplete closure or without closure were 25% and 15.6%, respectively. 69 Similarly, a recent systematic review analyzing four retrospective studies revealed protection of the post‐ER wound reduced more than 80% of the risk of delayed AE. 73 Closing the mucosal defect enables to manage the patients conservatively in case of intraprocedural perforation as well as to avoid delayed AE. Fukuhara et al. reported closing the whole mucosal defect, not only perforation site improved clinical outcomes of patients with intraprocedural perforation, and the maximum CRP level and hospital stay were equivalent to those without perforation if the mucosal defect was closed completely 68 (Figure 6).

FIGURE 5.

FIGURE 5

String clip suturing method for a large mucosal defect. (a) A 40 mm‐flat elevated lesion was found in descending duodenum. (b, c) The wound was approximated by pulling a string tightened to the clip. (d, e) The string was cut by scissors forceps and additional clips were deployed. (f) The wound was completely closed

FIGURE 6.

FIGURE 6

Complete closure of the mucosal defect in the case with intraprocedural perforation. (a) A 5 mm perforation occurred during submucosal dissection. (b) The wound was approximated by pulling string tightened to the clip. (c) The whole mucosal defect was completely closed. The post‐procedural clinical course was non‐eventful and the patient was discharged post procedural day 4

Although wound protection after duodenal ER is warranted to prevent delayed incidents, there are also several issues to be solved. Certain kinds of devices and materials are expensive: an Over‐The‐Scope Clips costs 79,800 JPY, the polyglycolic acid sheet itself costs 16,400 JPY, and the fibrin glue costs 34,017 JPY. Moreover, fibrin glue is a blood product derived from donated blood, and there is a low but non‐negligible risk of infection. The string clip suturing method requires only endoclips and a string, those are relatively cheap, however, it is technically challenging and it is sometimes impossible to achieve complete closure even by highly experienced endoscopists, depending on the location and lateral extent of the lesion. Recently, Mizutani et al. analyzed the risk factors for incomplete closure after duodenal ER and they found medial/anterior wall of lesion location and larger lesion size (especially >40mm) were independent predictors for incomplete closure. 74

Another means to prevent delayed AE is to suture the wound from outside the duodenum by laparoscopy. This novel surgical approach named endoscopic cooperative surgery (D‐LECS) was first reported by Irino et al. in 2015. 75 Recently a multi‐center retrospective case series including a total of 206 cases underwent D‐LECS revealed favorable outcomes with 95% of R0 resection rate and 4.4% of Clavien‐Dindo classification of three or more (perforation 1.5%, stenosis 1.9%, and bleeding 1%). 76

Moreover, external drainage of bile and pancreatic juice has been suggested for the management of post duodenal ER AE. Fukuhara et al. reported endoscopic naso‐biliary and naso‐pancreatic duct drainage could enable to manage delayed perforation conservatively without any invasive intervention 77 (Figure 7). Although the incidence of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis was 16% in this study, it would be an option for salvage treatment for the cases complete closure of the wound is impossible, considering the high morbidity rate of surgical treatment.

FIGURE 7.

FIGURE 7

Endoscopic naso‐biliary and naso‐pancreatic drainage (ENBPD) in the case with delayed perforation. (a) Delayed perforation occurred post 2 days after duodenal endoscopic submucosal dissection (ESD). (b, c) We tried to close the perforation with a clip, but due to the fragility of the tissue, the perforation was rather enlarged as a result. (d) Perforated area covered with PGA sheet. (e, f) ENBPD tubes were inserted and the post‐procedural clinical course was non‐eventful without any additional intervention

CRITERIA FOR CURABILITY

Due to the rarity of its incidence, information regarding the curability of ER for SNADET is not still enough. There is no concept of “early duodenal cancer”, on the contrary to other gastrointestinal tract tumors. With regard to the risk for lymph node metastasis (LNM), an analysis of intra‐mucosal duodenal cancer showed no incidence of LNM. 78 Therefore, intra‐mucosal cancers can be cured ER alone if free resection margin is confirmed pathologically. On the other hand, the incidence of LNM in submucosal cancer is reported to be up to 42%. 78 , 79 , 80 These cases would be candidates for additional surgical resection. However, these studies included only a small number of the lesions with LNM, and the detailed incidence of LNM and its risk factors remains unclear.

SURVEILLANCE AFTER TREATMENT

Recurrence after endoscopic treatment of superficial duodenal tumors can be divided into local residual recurrence and metachronous multiple lesions. For local recurrence, seven studies including more than 50 cases with a follow‐up period of more than 18 months have been reported. Of these, four were from Japan 22 , 24 , 58 , 60 and three were from Europe and Oceania. 59 , 61 , 62 The local recurrence rate ranged from 0 to 27.3% and was polarized between low reports (<5%) and high reports (>20%). When these studies were examined in terms of the availability of en bloc resection, all of the reports with high recurrence rates had high piecemeal resection rates. 60 , 61 , 62 Regarding the treatment of locally recurrent lesions, only 0.6% required surgical resection, and most of them could be treated by endoscopic treatment again and there were no reported deaths due to recurrent lesions. The cost of surveillance was reported by Klein et al., 62 that endoscopic treatment, including surveillance, was superiorly cheaper than surgical treatment of duodenal tumors.

Regarding the method of endoscopic surveillance, most of the above reports show that the first endoscopy is performed after 6 months–1 year, and if there is no recurrence, follow‐up with endoscopy is performed annually thereafter, suggesting that endoscopic surveillance is necessary at least once a year for patients who underwent segmental resection in the ER. On the other hand, there are currently few reports on heterogeneous multiple lesions, and the details are still unclear.

FUTURE PERSPECTIVE

For relatively small SNADETs, recently reported new treatment methods, such as UEMR and related techniques and CP, have improved the results. It is expected that these new ER techniques will be widely used as a standard treatment after the long‐term outcomes are elucidated.

Duodenal ESD is still a technically challenging procedure, but one of its advantages is its secure en bloc resection for large lesions. Accumulating evidence suggests wound protection could prevent delayed AE regardless of the presence or absence of intraoperative perforation. It is warranted that a simpler and more reliable method of wound protection will be developed in the future.

We believe that the process of overcoming the difficulty of duodenal ER would contribute to the further progress of endoscopy by discovering unmet medical demands.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

FUNDING INFORMATION

None.

REFERENCES

  • 1. Murray MA, Zimmerman MJ, Ee HC. Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut 2004; 53: 261–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Burgerman A, Baggenstoss AH, Cain JC. Primary malignant neoplasms of the duodenum, exclusing the papilla of vater; a clinicopathologic study of 31 cases. Gastroenterology 1956; 30: 421–31. [PubMed] [Google Scholar]
  • 3. Barclay TH, Kent HP. Primary carcinoma of the duodenum. Gastroenterology 1956; 30: 432–46. [PubMed] [Google Scholar]
  • 4. Arai T, Murata T, Sawabe M, Takubo K, Esaki Y. Primary adenocarcinoma of the duodenum in the elderly: Clinicopathological and immunohistochemical study of 17 cases. Pathol Int 1999; 49: 23–9. [DOI] [PubMed] [Google Scholar]
  • 5. Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004; 11: 301–9. [DOI] [PubMed] [Google Scholar]
  • 6. Kim HK, Lo SK. Endoscopic approach to the patient with benign or malignant ampullary lesions. Gastrointest Endosc Clin N Am 2013; 23: 347–83. [DOI] [PubMed] [Google Scholar]
  • 7. Kakushima N, Kanemoto H, Tanaka M, Takizawa K, Ono H. Treatment for superficial non‐ampullary duodenal epithelial tumors. World J Gastroenterol 2014; 20: 12501–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Goda K, Kikuchi D, Yamamoto Y, et al. Endoscopic diagnosis of superficial non‐ampullary duodenal epithelial tumors in Japan: Multicenter case series. Dig Endosc 2014; 26(Suppl 2): 23–9. [DOI] [PubMed] [Google Scholar]
  • 9. Yoshida M, Yabuuchi Y, Kakushima N, et al. The incidence of non‐ampullary duodenal cancer in Japan: The first analysis of a national cancer registry. J Gastroenterol Hepatol 2021; 36: 1216–21. [DOI] [PubMed] [Google Scholar]
  • 10. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997; 226: 248–57; discussion 57–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244: 10–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Kim J, Choi SH, Choi DW, Heo JS, Jang KT. Role of transduodenal ampullectomy for tumors of the ampulla of Vater. J Korean Surg Soc 2011; 81: 250–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kemp CD, Russell RT, Sharp KW. Resection of benign duodenal neoplasms. Am Surg 2007; 73: 1086–91. [PubMed] [Google Scholar]
  • 14. Asbun HJ. Management of duodenal polyps in the era of maximal interventional endoscopy and minimally invasive surgery: A surgical perspective. Gastrointest Endosc 2016; 84: 697–9. [DOI] [PubMed] [Google Scholar]
  • 15. Kinoshita S, Nishizawa T, Ochiai Y, et al. Accuracy of biopsy for the preoperative diagnosis of superficial nonampullary duodenal adenocarcinoma. Gastrointest Endosc 2017; 86: 329–32. [DOI] [PubMed] [Google Scholar]
  • 16. Inoue T, Uedo N, Yamashina T, et al. Delayed perforation: A hazardous complication of endoscopic resection for non‐ampullary duodenal neoplasm. Dig Endosc 2014; 26: 220–7. [DOI] [PubMed] [Google Scholar]
  • 17. Honda T, Yamamoto H, Osawa H, et al. Endoscopic submucosal dissection for superficial duodenal neoplasms. Dig Endosc 2009; 21: 270–4. [DOI] [PubMed] [Google Scholar]
  • 18. Takahashi T, Ando T, Kabeshima Y, et al. Borderline cases between benignancy and malignancy of the duodenum diagnosed successfully by endoscopic submucosal dissection. Scand J Gastroenterol 2009; 44: 1377–83. [DOI] [PubMed] [Google Scholar]
  • 19. Jung JH, Choi KD, Ahn JY, et al. Endoscopic submucosal dissection for sessile, nonampullary duodenal adenomas. Endoscopy 2013; 45: 133–5. [DOI] [PubMed] [Google Scholar]
  • 20. Matsumoto S, Miyatani H, Yoshida Y. Endoscopic submucosal dissection for duodenal tumors: A single‐center experience. Endoscopy 2013; 45: 136–7. [DOI] [PubMed] [Google Scholar]
  • 21. Kakushima N. Hurdles of duodenal endoscopic submucosal dissection, delayed bleeding and perforation. Dig Endosc 2015; 27: 298–9. [DOI] [PubMed] [Google Scholar]
  • 22. Nonaka S, Oda I, Tada K, et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129–35. [DOI] [PubMed] [Google Scholar]
  • 23. Endo M, Abiko Y, Oana S, et al. Usefulness of endoscopic treatment for duodenal adenoma. Dig Endosc 2010; 22: 360–5. [DOI] [PubMed] [Google Scholar]
  • 24. Hoteya S, Furuhata T, Takahito T, Fukuma Y, Suzuki Y, Kikuchi D, et al. Endoscopic submucosal dissection and endoscopic mucosal resection for non‐ampullary superficial duodenal tumor. Digestion 2017; 95: 36–42. [DOI] [PubMed] [Google Scholar]
  • 25. Yahagi N, Kato M, Ocihai Y, et al. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 2018; 88: 676–82. [DOI] [PubMed] [Google Scholar]
  • 26. Binmoeller KF, Shah JN, Bhat YM, Kane SD. “Underwater” EMR of sporadic laterally spreading nonampullary duodenal adenomas (with video). Gastrointest Endosc 2013; 78: 496–502. [DOI] [PubMed] [Google Scholar]
  • 27. Yamasaki Y, Uedo N, Takeuchi Y, et al. Underwater endoscopic mucosal resection for superficial nonampullary duodenal adenomas. Endoscopy 2018; 50: 154–8. [DOI] [PubMed] [Google Scholar]
  • 28. Shibukawa G, Irisawa A, Sato A, et al. Endoscopic mucosal resection performed underwater for nonampullary duodenal epithelial tumor: Evaluation of feasibility and safety. Gastroenterol Res Pract 2018; 2018: 7490961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Kiguchi Y, Kato M, Nakayama A, et al. Feasibility study comparing underwater endoscopic mucosal resection and conventional endoscopic mucosal resection for superficial non‐ampullary duodenal epithelial tumor < 20 mm. Dig Endosc 2020; 32: 753–60. [DOI] [PubMed] [Google Scholar]
  • 30. Iwagami H, Takeuchi Y, Yamasaki Y, et al. Feasibility of underwater endoscopic mucosal resection and management of residues for superficial non‐ampullary duodenal epithelial neoplasms. Dig Endosc 2020; 32: 565–73. [DOI] [PubMed] [Google Scholar]
  • 31. Hirasawa K, Ozeki Y, Sawada A, et al. Appropriate endoscopic treatment selection and surveillance for superficial non‐ampullary duodenal epithelial tumors. Scand J Gastroenterol 2021; 56: 342–50. [DOI] [PubMed] [Google Scholar]
  • 32. Furukawa M, Mitoro A, Ozutumi T, et al. Efficacy of underwater endoscopic mucosal resection for superficial non‐ampullary duodenal epithelial tumor. Clin Endosc 2021; 54: 371–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Shichijo S, Uedo N, Takeuchi Y, et al. Underwater endoscopic mucosal resection of residual duodenal tumor. Endoscopy 2019; 51: E329–30. [DOI] [PubMed] [Google Scholar]
  • 34. Yamasaki Y, Uedo N, Akamatsu T, et al. Non‐recurrence rate of underwater EMR for ≤20‐mm non‐ampullary duodenal adenomas: A multicenter prospective study (D‐UEMR study). Clin Gastroenterol Hepatol 2021; S1542‐3565(21)00707‐2. [DOI] [PubMed] [Google Scholar]
  • 35. Takatori Y, Kato M, Nakayama A, Yahagi N. A case of duodenal tumor adjacent to the diverticulum that was resected by the technique of partial submucosal injection combined with underwater endoscopic mucosal resection. Dig Dis 2021; 39: 70–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Takatori Y, Kato M, Masunaga T, et al. Feasibility study of partial submucosal injection technique combining underwater emr for superficial duodenal epithelial tumors. Dig Dis Sci. Published online: 15 Mar 2021; DOI: 10.1007/s10620-021-06925-3 [DOI] [PubMed] [Google Scholar]
  • 37. Yamamoto K, Kanomata N, Ikeya T. Utility of under‐gel endoscopic mucosal resection with partial submucosal injection for a laterally spreading tumor. Endoscopy. Published online: 15 Mar 2021; DOI: 10.1055/a-1381-6915 [DOI] [PubMed] [Google Scholar]
  • 38. Takeuchi Y, Mabe K, Shimodate Y, et al. Continuous anticoagulation and cold snare polypectomy versus heparin bridging and hot snare polypectomy in patients on anticoagulants with subcentimeter polyps: A randomized controlled trial. Ann Intern Med 2019; 171: 229–37. [DOI] [PubMed] [Google Scholar]
  • 39. Maruoka D, Arai M, Ishigami H, et al. Cold polypectomy for nonampullary duodenal adenoma. Endoscopy 2015; 47(S 01): E477–8. [DOI] [PubMed] [Google Scholar]
  • 40. Hamada K, Takeuchi Y, Ishikawa H, et al. Safety of cold snare polypectomy for duodenal adenomas in familial adenomatous polyposis: A prospective exploratory study. Endoscopy 2018; 50: 511–7. [DOI] [PubMed] [Google Scholar]
  • 41. Akimoto T, Kato M, Yahagi N. Severe acute pancreatitis following cold polypectomy of the minor duodenal papilla in a case with pancreas divisum. Dig Endosc 2020; 32: 151. [DOI] [PubMed] [Google Scholar]
  • 42. Suzuki S, Gotoda T, Kusano C, et al. Width and depth of resection for small colorectal polyps: Hot versus cold snare polypectomy. Gastrointest Endosc 2018; 87: 1095–103. [DOI] [PubMed] [Google Scholar]
  • 43. Kato M, Shiraishi J, Uraoka T. Second local recurrence with advanced rectal cancer after salvage endoscopic mucosal resection of local recurrence following initial cold polypectomy. Dig Endosc 2017; 29: 636. [DOI] [PubMed] [Google Scholar]
  • 44. Kato M, Nishida T, Hamasaki T, et al. Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: A propensity score analysis. Surg Endosc 2015; 29: 1560–6. [DOI] [PubMed] [Google Scholar]
  • 45. Tsujii Y, Nishida T, Nishiyama O, et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: A multicenter retrospective cohort study. Endoscopy 2015; 47: 775–83. [DOI] [PubMed] [Google Scholar]
  • 46. Saito Y, Uraoka T, Yamaguchi Y, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc 2010; 72: 1217–25. [DOI] [PubMed] [Google Scholar]
  • 47. Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: A multicentre retrospective cohort study by Osaka University ESD study group. Gut 2013; 62: 1425–32. [DOI] [PubMed] [Google Scholar]
  • 48. Draganov PV, Aihara H, Karasik MS, et al. Endoscopic submucosal dissection in North America: A large prospective multicenter study. Gastroenterology 2021; 160: 2317–27. e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Esaki M, Haraguchi K, Akahoshi K, et al. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non‐ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12: 918–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Kuroki K, Sanomura Y, Oka S, et al. Clinical outcomes of endoscopic resection for superficial non‐ampullary duodenal tumors. Endosc Int Open 2020; 8: E354–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Tashima T, Ohata K, Sakai E, et al. Efficacy of an over‐the‐scope clip for preventing adverse events after duodenal endoscopic submucosal dissection: A prospective interventional study. Endoscopy 2018; 50: 487–96. [DOI] [PubMed] [Google Scholar]
  • 52. Matsuda Y, Sakamoto K, Kataoka N, Yamaguchi T, Tomita M, Makimoto S. Perforation associated with endoscopic submucosal dissection for duodenal neoplasm without a papillary portion. World J Gastrointest Surg 2017; 9: 161–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Miura Y, Shinozaki S, Hayashi Y, Sakamoto H, Lefor AK, Yamamoto H. Duodenal endoscopic submucosal dissection is feasible using the pocket‐creation method. Endoscopy 2017; 49: 8–14. [DOI] [PubMed] [Google Scholar]
  • 54. Ishii N, Akiyama H, Suzuki K, Fujita Y. Safety and efficacy of endoscopic submucosal dissection for non‐ampullary duodenal neoplasms: A case series. ACG Case Rep J 2015; 2: 146–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Matsumoto S, Yoshida Y. Selection of appropriate endoscopic therapies for duodenal tumors: An open‐label study, single‐center experience. World J Gastroenterol 2014; 20: 8624–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Yamamoto Y, Yoshizawa N, Tomida H, Fujisaki J, Igarashi M. Therapeutic outcomes of endoscopic resection for superficial non‐ampullary duodenal tumor. Dig Endosc 2014; 26(Suppl 2): 50–6. [DOI] [PubMed] [Google Scholar]
  • 57. Kakushima N, Ono H, Takao T, Kanemoto H, Sasaki K. Method and timing of resection of superficial non‐ampullary duodenal epithelial tumors. Dig Endosc 2014; 26(Suppl 2): 35–40. [DOI] [PubMed] [Google Scholar]
  • 58. Hara Y, Goda K, Dobashi A, et al. Short‐ and long‐term outcomes of endoscopically treated superficial non‐ampullary duodenal epithelial tumors. World J Gastroenterol 2019; 25: 707–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Valli PV, Mertens JC, Sonnenberg A, Bauerfeind P. Nonampullary duodenal adenomas rarely recur after complete endoscopic resection: A Swiss experience including a literature review. Digestion 2017; 96: 149–57. [DOI] [PubMed] [Google Scholar]
  • 60. Tomizawa Y, Ginsberg GG. Clinical outcome of EMR of sporadic, nonampullary, duodenal adenomas: A 10‐year retrospective. Gastrointest Endosc 2018; 87: 1270–8. [DOI] [PubMed] [Google Scholar]
  • 61. Valerii G, Tringali A, Landi R, et al. Endoscopic mucosal resection of non‐ampullary sporadic duodenal adenomas: A retrospective analysis with long‐term follow‐up. Scand J Gastroenterol 2018; 53: 490–4. [DOI] [PubMed] [Google Scholar]
  • 62. Klein A, Ahlenstiel G, Tate DJ, et al. Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery. Endoscopy 2017;. 49: 659–67. [DOI] [PubMed] [Google Scholar]
  • 63. Kato M, Sasaki M, Mizutani M, et al. Predictors of technical difficulty with duodenal ESD. Endosc Int Open 2019; 7: E1755–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Yahagi N, Nishizawa T, Sasaki M, Ochiai Y, Uraoka T. Water pressure method for duodenal endoscopic submucosal dissection. Endoscopy 2017; 49: E227–8. [DOI] [PubMed] [Google Scholar]
  • 65. Kato M, Takatori Y, Sasaki M, et al. Water pressure method for duodenal endoscopic submucosal dissection (with video). Gastrointest Endosc 2021; 93: 942–9. [DOI] [PubMed] [Google Scholar]
  • 66. Dohi O, Yoshida N, Naito Y, et al. Efficacy and safety of endoscopic submucosal dissection using a scissors‐type knife with prophylactic over‐the‐scope clip closure for superficial non‐ampullary duodenal epithelial tumors. Dig Endosc 2020; 32: 904–13. [DOI] [PubMed] [Google Scholar]
  • 67. Kaku H, Toyonaga T, Tanaka S, et al. Endoscopic submucosal dissection using EndoTrac, a novel traction device. Digestion. Published online: 22 Dec 2020; DOI: 10.1159/000511731 [DOI] [PubMed] [Google Scholar]
  • 68. Fukuhara S, Kato M, Iwasaki E, et al. Management of perforation related to endoscopic submucosal dissection for superficial duodenal epithelial tumors. Gastrointest Endosc 2019; 91: 1129–37. [DOI] [PubMed] [Google Scholar]
  • 69. Kato M, Ochiai Y, Fukuhara S, et al. Clinical impact of closure of the mucosal defect after duodenal endoscopic submucosal dissection. Gastrointest Endosc 2018; 89: 87–93. [DOI] [PubMed] [Google Scholar]
  • 70. Maruoka D, Arai M, Kishimoto T, et al. Clinical outcomes of endoscopic resection for nonampullary duodenal high‐grade dysplasia and intramucosal carcinoma. Endoscopy 2013; 45: 138–41. [DOI] [PubMed] [Google Scholar]
  • 71. Mori H, Ayaki M, Kobara H, et al. Suitable closure for post‐duodenal endoscopic resection taking medical costs into consideration. World J Gastroenterol 2015; 21: 5281–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Yahagi N, Nishizawa T, Akimoto T, Ochiai Y, Goto O. New endoscopic suturing method: String clip suturing method. Gastrointest Endosc 2016; 84: 1064‐5. [DOI] [PubMed] [Google Scholar]
  • 73. Tsutsumi K, Kato M, Kakushima N, et al. Efficacy of endoscopic preventive procedures to reduce delayed adverse events after endoscopic resection of superficial nonampullary duodenal epithelial tumors: A meta‐analysis of observational comparative trials. Gastrointest Endosc 2021; 93: 367–74.e3. [DOI] [PubMed] [Google Scholar]
  • 74. Mizutani M, Kato M, Sasaki M, et al. Predictors of technical difficulty for complete closure of mucosal defects after duodenal endoscopic resection. Gastrointest Endosc 2021; S0016‐5107(21)01315‐8. [DOI] [PubMed] [Google Scholar]
  • 75. Irino T, Nunobe S, Hiki N, et al. Laparoscopic‐endoscopic cooperative surgery for duodenal tumors: A unique procedure that helps ensure the safety of endoscopic submucosal dissection. Endoscopy 2015; 47: 349–51. [DOI] [PubMed] [Google Scholar]
  • 76. Nunobe S, Ri M, Yamazaki K, et al. Safety and feasibility of laparoscopic and endoscopic cooperative surgery for duodenal neoplasm: A retrospective multicenter study. Endoscopy. Published online 2 Dec 2020; DOI: 10.1055/a-1327-5939 [DOI] [PubMed] [Google Scholar]
  • 77. Fukuhara S, Kato M, Iwasaki E, et al. External drainage of bile and pancreatic juice after endoscopic submucosal dissection for duodenal neoplasm: Feasibility study (with video). Dig Endosc. Published online: 30 Nov 2020; DOI: 10.1111/den.13907 [DOI] [PubMed] [Google Scholar]
  • 78. Sakamoto T, Saiura A, Ono Y, et al. Optimal lymphadenectomy for duodenal adenocarcinoma: Does the number alone matter? Ann Surg Oncol 2017; 24: 3368–75. [DOI] [PubMed] [Google Scholar]
  • 79. Jurisić D, Doko M, Glavan E, Rosko D, Vidović D, Tomić K. Local recurrence of primary non‐ampullary adenocarcinoma of duodenum after surgical treatment–a case report and a literature review. Coll Antropol 2006; 30: 225–9. [PubMed] [Google Scholar]
  • 80. Yoshimizu S, Kawachi H, Yamamoto Y, et al. Clinicopathological features and risk factors for lymph node metastasis in early‐stage non‐ampullary duodenal adenocarcinoma. J Gastroenterol 2020; 55: 754–62. [DOI] [PubMed] [Google Scholar]

Articles from DEN Open are provided here courtesy of Wiley

RESOURCES